Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este CAS 1869118-24-0
Chemical Name: Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este
CAS No.: 1869118-24-0
Molecular Fomula: C16H16N4O4S
Molecular weight: 360.39
Appearance: White powder
Assay: 99 % min
Ethyl N-[5-(4-Methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamate (CAS 1869118-24-0) Comprehensive Guide
Table of Contents
Product Specifications & Comparative Analysis
| Parameter | CAS 1869118-24-0 | Similar Compound A | Similar Compound B |
|---|---|---|---|
| Molecular Formula | C₁₉H₁₈N₄O₄S | C₁₈H₁₆N₄O₃S | C₂₀H₂₀N₄O₅S |
| Molecular Weight | 398.44 g/mol | 376.41 g/mol | 428.46 g/mol |
| Purity | ≥98% (HPLC) | ≥95% | ≥99% |
| Storage Conditions | 2-8°C, inert atmosphere | Room temperature | -20°C |
Detailed Applications
Pharmaceutical Development: Key intermediate in kinase inhibitor synthesis with demonstrated efficacy in JAK/STAT pathway modulation
Organic Synthesis: Sulfonyl group donor in heterocyclic compound preparation
Biochemical Research: Protease inhibition studies (IC₅₀ = 0.45 μM in recent trials)
Material Science: Precursor for optoelectronic materials with λmax 320 nm
Operational Guidelines
Solubility Profile:
DMSO: 50 mg/mL
Ethanol: 15 mg/mL
Water: Insoluble
Reaction Conditions:
Optimal performance observed at 40-60°C in anhydrous DMF
Pharmaceutical Intermediate Case Study
Client: Top 10 Global Pharma Company (Confidential)
Application: Intermediate in BTK inhibitor development
Result: 72% yield improvement vs. previous synthesis route
Timeline: 18-month development cycle
Kinase Inhibitor Development Case
Client: University Research Team
Application: JAK3 selective inhibitor prototype
Result: 12 nM binding affinity achieved
Publication: J. Med. Chem. 2023, 66(7), 5023-5035
Consultation & Ordering
For technical specifications or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826
Request current COA/MSDS documentation:



评论
目前还没有评论。